Nadia G. Tornieporth

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Prospective cohort study to evaluate Lassa fever incidence, symptoms and coinfection with malaria in West Africa: the Enable Lassa Research Programme ('ENABLE 1.5') - study protocol.

Prospective cohort study to evaluate Lassa fever incidence, symptoms and coinfection with malaria in West Africa: the Enable Lassa Research Programme ('ENABLE 1.5') - study protocol.

Journal: BMJ public health
Published: August 27, 2024

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults.

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults.

Journal: Vaccine
Published: June 13, 2023

The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: a qualitative assessment of sub-Sahara Africa investigators' perception.

The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: a qualitative assessment of sub-Sahara Africa investigators' perception.

Journal: The Pan African medical journal
Published: February 18, 2022

Medical countermeasures against henipaviruses: a review and public health perspective.

Medical countermeasures against henipaviruses: a review and public health perspective.

Journal: The Lancet. Infectious diseases
Published: April 30, 2021

Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.

Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.

Journal: Vaccine
Published: February 17, 2021

A descriptive cross-sectional study of cholera at Kakuma and Kalobeyei refugee camps, Kenya in 2018.

A descriptive cross-sectional study of cholera at Kakuma and Kalobeyei refugee camps, Kenya in 2018.

Journal: The Pan African medical journal
Published: July 04, 2020

A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries.

A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries.

Journal: Pilot and feasibility studies
Published: August 30, 2019

A review of Lassa fever vaccine candidates.

A review of Lassa fever vaccine candidates.

Journal: Current opinion in virology
Published: May 16, 2019

WHO preferred product characteristics for new vaccines against tuberculosis.

WHO preferred product characteristics for new vaccines against tuberculosis.

Journal: The Lancet. Infectious diseases
Published: May 25, 2018

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage.

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage.

Journal: Journal of clinical pharmacology
Published: December 14, 2017

Efficacy of a tetravalent dengue vaccine in children in Latin America.

Efficacy of a tetravalent dengue vaccine in children in Latin America.

Journal: The New England journal of medicine
Published: November 04, 2014

Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

Journal: The New England journal of medicine
Published: August 15, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026